Robert Letterio Oliva, Director at Novo Integrated Sciences, Inc. (NVOS), bought 10,000 shares at $2.25 ($22K) on 2022-04-20, disclosed to the SEC on 2022-04-21.
Open-market purchase of $22k NVOS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.23 | 5,000 | $11K | 50.0% |
| 2 | $2.23 | 4,700 | $10K | 47.0% |
| 3 | $2.25 | 300 | $675 | 3.0% |
| Total | $2.23 avg | 10,000 | $22K | 100% |
| Filing → |